Selecting the appropriate rodent diet for endocrine disruptor research and testing studies

ILAR J. 2004;45(4):401-16. doi: 10.1093/ilar.45.4.401.

Abstract

Selecting the optimum diet for endocrine disruptor (ED) research and testing studies in rodents is critical because the diet may determine the sensitivity to detect or properly evaluate an ED compound. Dietary estrogens can profoundly influence many molecular and cellular event actions on estrogen receptors and estrogen-sensitive genes. The source, concentration, relative potency, and significance of dietary estrogens in rodent diets are reviewed, including dietary factors that focus specifically on total metabolizable energy and phytoestrogen content, which potentially affect ED studies in rodents. Research efforts to determine dietary factors in commercially available rodent diets that affect uterotrophic assays and the time of vaginal opening in immature CD-1 mice are summarized. A checklist is provided of important factors to consider when selecting diets for ED research and testing studies in rodents. Specific metabolizable energy levels are recommended for particular bioassays. Discussions include the between-batch variation in content of the phytoestrogens daidzein and genistein, the effects of total metabolizable energy and phytoestrogens on the timing (i.e., acceleration) of vaginal opening, and increased uterine weight in immature CD-1 mice. It is concluded that rodent diets differ significantly in estrogenic activity primarily due to the large variations in phytoestrogen content; therefore animal diets used in all ED studies should ideally be free of endocrine-modulating compounds.

Publication types

  • Review

MeSH terms

  • Animal Feed*
  • Animal Husbandry
  • Animals
  • Diet*
  • Endocrine Glands / drug effects*
  • Endocrine Glands / pathology
  • Endocrine Glands / physiopathology
  • Environmental Exposure / adverse effects
  • Female
  • Hormone Antagonists / toxicity*
  • Mice
  • Research Design*
  • Toxicity Tests / methods*

Substances

  • Hormone Antagonists